# IronDeficiency Across Neurodevelopmental Disorders: Comparative Insights from ADHD and Autism Spectrum Disorder

**Authors:** Lourdes M. DelRosso, Lilliana Estrada Chaverri, Fernando Alberto Ceballos Fuentes

PMC · DOI: 10.3390/children13020180 · Children · 2026-01-28

## TL;DR

Iron deficiency is linked to ADHD and autism, with brain iron levels and sleep issues being key areas of concern, suggesting iron screening and supplementation could help improve symptoms.

## Contribution

The paper synthesizes evidence on iron deficiency in ADHD and ASD, highlighting distinct neurobehavioral and therapeutic implications for each disorder.

## Key findings

- ADHD is associated with reduced brain iron in dopaminergic regions, though peripheral iron markers show inconsistent links to symptoms.
- In ASD, low ferritin is consistently tied to sleep-related motor disturbances, and iron supplementation improves sleep outcomes.
- Iron screening and supplementation may benefit children with ADHD and ASD, especially those with sleep issues or poor treatment response.

## Abstract

What are the main findings?
•In children with ADHD, neuroimaging studies show reduced brain iron in key dopaminergic regions, although peripheral iron markers and their association with ADHD-related symptoms are inconsistent.•In autism spectrum disorder, low ferritin is consistently associated with sleep-related motor disturbances, and iron supplementation improves sleep outcomes.

In children with ADHD, neuroimaging studies show reduced brain iron in key dopaminergic regions, although peripheral iron markers and their association with ADHD-related symptoms are inconsistent.

In autism spectrum disorder, low ferritin is consistently associated with sleep-related motor disturbances, and iron supplementation improves sleep outcomes.

What are the implication of the main finding?
•Evaluation of iron status should be considered in children with ADHD and ASD, particularly in those with sleep disturbances, motor restlessness, or suboptimal response to standard treatments.•Iron supplementation, when guided by laboratory monitoring, may serve as a useful adjunctive therapy to improve sleep and selected functional outcomes.

Evaluation of iron status should be considered in children with ADHD and ASD, particularly in those with sleep disturbances, motor restlessness, or suboptimal response to standard treatments.

Iron supplementation, when guided by laboratory monitoring, may serve as a useful adjunctive therapy to improve sleep and selected functional outcomes.

Background: Iron plays a crucial role in neurotransmitter synthesis, myelination, and neuronal metabolism. Iron deficiency has been associated with a variety of neurodevelopmental disorders, particularly attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). However, the prevalence, clinical impact, and treatment implications differ between these conditions. Objective: To synthesize current evidence on the prevalence, neurobehavioral consequences, and therapeutic implications of iron deficiency in ADHD and ASD, highlighting convergences and disorder-specific findings. Results: In ADHD, studies using serum ferritin and related peripheral markers show inconsistent associations with core symptom severity, with reported ferritin thresholds for deficiency ranging widely. While some studies suggest links between low ferritin and hyperactivity, inattention, or stimulant response, others report null findings. In contrast, emerging neuroimaging evidence consistently demonstrates reduced brain iron in dopaminergic regions in children. In ASD, the strongest link is between low ferritin and sleep-related motor disturbances, and iron supplementation may improve sleep and motor symptoms. Conclusions: Screening for iron status and targeted supplementation may improve sleep and behavioral outcomes in ADHD and ASD, meriting integration into clinical practice and further randomized controlled trials.

## Linked entities

- **Diseases:** attention-deficit/hyperactivity disorder (MONDO:0007743), autism spectrum disorder (MONDO:0005258)

## Full-text entities

- **Genes:** HAMP (hepcidin antimicrobial peptide) [NCBI Gene 57817] {aka HEPC, HFE2B, LEAP1, PLTR}, TFRC (transferrin receptor) [NCBI Gene 7037] {aka CD71, IMD46, T9, TFR, TFR1, TR}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, PAH (phenylalanine hydroxylase) [NCBI Gene 5053] {aka PH, PKU, PKU1}, TH (tyrosine hydroxylase) [NCBI Gene 7054] {aka DYT14, DYT5b, TYH}
- **Diseases:** Sleep fragmentation (MESH:D012892), impulsivity (MESH:D007174), constipation (MESH:D003248), RLS (MESH:D012148), Neurodevelopmental Disorders (MESH:D002658), neuropsychiatric and cognitive symptoms (MESH:D003072), restless sleep (MESH:C000715309), anemia (MESH:D000740), -related symptoms (MESH:D012816), nutritional deficiencies (MESH:D044342), intellectual disability.4 (MESH:D008607), hematologic (MESH:D006402), infection (MESH:D007239), motor restlessness (MESH:D011595), ADHD (MESH:D001289), social-communication symptoms (MESH:D000067404), weight gain (MESH:D015430), externalizing, and attention-related problems (MESH:D000076082), periodic (MESH:D010505), obesity (MESH:D009765), sleep-related motor (MESH:D020183), fatigue (MESH:D005221), behavioral dysregulation (MESH:D021081), iron-deficiency anemia (MESH:D018798), hyperactivity (MESH:D006948), Iron Deficiency (MESH:D000090463), inflammation (MESH:D007249), injury to (MESH:D014947), parasomnia (MESH:D020447), iron overload (MESH:D019190), inattention (MESH:D001308), Aspergers (MESH:D020817), PLMS (MESH:D020189), sleep disorders (MESH:D012893), ASD (MESH:D000067877), ID (MESH:C537985), insomnia (MESH:D007319), microcytosis (OMIM:616959), irritability (MESH:D001523), hyperferritinemia (MESH:D000085583), autism (MESH:D001321), disruptive behaviors (MESH:D019958), anxiety (MESH:D001007)
- **Chemicals:** Glutamine (MESH:D005973), lead (MESH:D007854), dopamine (MESH:D004298), gabapentin (MESH:D000077206), Mg (MESH:D008274), serotonin (MESH:D012701), polyunsaturated fatty acid (MESH:D005231), catecholamines (MESH:D002395), heme (MESH:D006418), MPH (MESH:D008774), fatty acids (MESH:D005227), zinc oxide (MESH:D015034), Ferrous Fumarate (MESH:C031621), Iron (MESH:D007501), norepinephrine (MESH:D009638), Zinc protoporphyrin (MESH:C017803), risperidone (MESH:D018967), metal (MESH:D008670), ferric carboxymaltose (MESH:C522335), zinc (MESH:D015032), ferrous sulfate (MESH:C020748)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938977/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12938977/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938977/full.md

---
Source: https://tomesphere.com/paper/PMC12938977